You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Higher-Grade Transformation

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gut Microbiota Diversity in Children Aged 1-3 Years on Prolonged

Active, not recruiting
  • Vesicoureteral Reflux 3
  • Stool sampling
  • Montpellier, France
  • +1 more
Sep 23, 2022

Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome, Previously Treated Myelodysplastic Syndrome Trial in United

Completed
  • Chronic Myelomonocytic Leukemia
  • +4 more
  • Los Angeles, California
  • +4 more
Oct 5, 2022

Cerebral Infarction Trial in Madrid (Subcutaneous blood glucose monitoring device)

Recruiting
  • Cerebral Infarction
  • Subcutaneous blood glucose monitoring device
  • Madrid, Spain
    Hospital Universitario La Paz
May 12, 2023

Glioma, Gliomas, High Grade Glioma Trial run by the National Cancer Institute (NCI) (3T MRI scanner)

Recruiting
  • Glioma
  • +4 more
  • 3T MRI scanner
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Alcohol Drinking, Tobacco Use, Substance Use Trial in Seattle (Journey of Transformation-Native Youth Health Leadership Program

Not yet recruiting
  • Alcohol Drinking
  • +3 more
  • Journey of Transformation-Native Youth Health Leadership Program curriculum
  • Seattle, Washington
    University of Washington
Feb 7, 2023

Cervical Dysplasia Trial (LLETZ)

Not yet recruiting
  • Cervical Dysplasia
  • LLETZ
  • Herne, North Rhine-Westphalia, Germany
    Marien Hospital Herne
Jan 24, 2023

Based Female Genital HPV Induced Dysplasia and Cancer Screening

Not yet recruiting
  • Cervical Dysplasia, Uterine
  • +2 more
    • (no location specified)
    Sep 7, 2022

    Alcohol Use, Tobacco Use, Substance Use Trial in Seattle (Journey of Transformation-Native Youth Health Leadership Program

    Not yet recruiting
    • Alcohol Use
    • +3 more
    • Journey of Transformation-Native Youth Health Leadership Program curriculum
    • Seattle, Washington
      University of Washington
    Mar 1, 2022

    Glioma Trial in Oxford (Fluorodopa PET tracer)

    Recruiting
    • Glioma
    • Fluorodopa PET tracer
    • Oxford, Oxfordshire, United Kingdom
      Oxford University Hospitals NHS Foundation Trust
    Jul 28, 2022

    Hematopoietic/Lymphoid Cancer, Richter's Transformation Trial in Houston (Blinatumomab, Dexamethasone)

    Completed
    • Hematopoietic/Lymphoid Cancer
    • Richter's Transformation
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Mar 3, 2022

    Endometrial Carcinoma, Tumor Molecular Features Screening Model Trial (open surgery, laparoscopic surgery)

    Not yet recruiting
    • Endometrial Carcinoma
    • Tumor Molecular Features Screening Model
    • open surgery
    • laparoscopic surgery
    • (no location specified)
    Jun 7, 2023

    Oligodendroglioma, Astrocytoma, Grade II, Glioma, Astrocytic Trial in San Francisco (GBM6-AD and poly-ICLC before and after

    Active, not recruiting
    • Oligodendroglioma
    • +5 more
    • GBM6-AD and poly-ICLC before and after surgery
    • GBM6-AD and poly-ICLC after surgery only
    • San Francisco, California
      University of California
    Sep 20, 2022

    Cervical Dysplasia Trial in Herne (Lugol's iodine test)

    Recruiting
    • Cervical Dysplasia
    • Lugol's iodine test
    • Herne, NRW, Germany
      Marien Hospital Herne
    Aug 19, 2022

    Chronic Lymphocytic Leukemia, Richter Syndrome, Small Lymphocytic Lymphoma Trial in Rochester (Acalabrutinib, Durvalumab,

    Recruiting
    • Chronic Lymphocytic Leukemia
    • +2 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 4, 2023

    Parturition, Depression, Postpartum Trial in Katowice (Shantali massage)

    Completed
    • Parturition
    • Depression, Postpartum
    • Shantali massage
    • Katowice, Poland
      The Jerzy Kukuczka Academy of Physical Education
    Apr 19, 2023

    Low-grade Oral Dysplasia Trial in Boston (Probiotic oral lozenges, Standard of care for oral dysplasia)

    Not yet recruiting
    • Low-grade Oral Dysplasia
    • Probiotic oral lozenges
    • Standard of care for oral dysplasia
    • Boston, Massachusetts
      Boston Medical Center
    Jan 22, 2023

    High Risk Myelodysplastic Syndrome Trial in Houston (Guadecitabine)

    Active, not recruiting
    • High Risk Myelodysplastic Syndrome
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 2, 2022

    Loss of Chromosome 17p, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Houston (drug,

    Completed
    • Loss of Chromosome 17p
    • +5 more
    • Houston, Texas
      M D Anderson Cancer Center
    Mar 4, 2022

    CLL Transformation Trial in Italy, Switzerland (Obinutuzumab 25 MG/ML [Gazyva], Atezolizumab 60 MG/ML [Tecentriq], Venetoclax

    Recruiting
    • CLL Transformation
    • Obinutuzumab 25 MG/ML [Gazyva]
    • +2 more
    • Alessandria, Italy
    • +16 more
    Sep 27, 2022

    Squamous Cell Carcinoma of Head and Neck Trial in Italy (Nivolumab 240 MG in 24 ML Injection)

    Completed
    • Squamous Cell Carcinoma of Head and Neck
    • Nivolumab 240 MG in 24 ML Injection
    • Bergamo, Italy
    • +22 more
    Apr 4, 2023

    Relapsed/Refractory Follicular Lymphoma Trial in Nashville (Axicabtagene Ciloleucel, Cyclophosphamide, Fludarabine)

    Recruiting
    • Relapsed/Refractory Follicular Lymphoma
    • Axicabtagene Ciloleucel
    • +8 more
    • Denver, Colorado
    • +6 more
    Dec 2, 2022

    Myelodysplastic Syndrome, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute Trial in Worldwide (Azacitidine,

    Active, not recruiting
    Has Results
    • Myelodysplastic Syndrome
    • +2 more
    • Daphne, Alabama
    • +241 more
    Dec 23, 2022

    Lymphoma, Follicular Trial (Mosunetuzumab)

    Not yet recruiting
    • Lymphoma, Follicular
    • (no location specified)
    May 8, 2023

    Oral Potentially Malignant Disorders (OPMDs) With STRATICYTE™

    Recruiting
    • Mouth Diseases
    • STRATICYTE™ Test
    • Birmingham, Alabama
    • +3 more
    May 2, 2023

    Chronic Lymphocytic Leukemia, Richter's Transformation Trial in Boston (Glofitamab, Obinutuzumab, Polatuzumab Vedotin)

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • Richter's Transformation
    • Boston, Massachusetts
    • +1 more
    Sep 12, 2023